Cancer Care Associates of York has partnered with San Francisco, California-based House Rx, to more efficiently integrate specialty medicine dispensing.
House Rx, a platform for medically integrated dispensing of specialty medications for cancer care, rheumatoid arthritis and other complex medical conditions, said the system is a seamless process where the physicians, clinical staff, pharmacists and technicians collaborate as one team to provide patient care.
Cancer Care Associates of York (CCAY), which has eight physicians and five advanced practice providers, began in-house medication dispensing in 2013.
“Our partnership with House Rx is going to hugely impact the breadth and quality of services we have to offer to our patients,” said Dr. Daniel Efiom-Ekaha, physician and president at CCAY. “This new relationship couldn’t have come at a better time; House Rx’s technology and support will be crucial in helping us scale our in-office dispensing services to meet the expanding needs and complexity of our unique oncologic patient population.”
Since launching in March 2021, House Rx has now partnered with eight specialty clinics across the U.S. to begin or enhance their in-house dispensing capabilities and has partnered with the National Cancer Treatment Alliance (NCTA) to develop software that provides analytics around the network’s physician dispensing quality measures, the company said.
In addition to superior drug initiation turnaround time, other benefits of the medically integrated dispensing model include reducing financial burden, improving medication adherence rates, and reducing accumulation of expensive therapies, House Rx said.